Punita kumar sinha biography of albert
•
Pharmacy benefit managers (PBMs) traditionally determine two things facing American taxpayers: the affordability and accessibility of drugs. According to industry expert Albert Thigpen, the scope of PBM’s influence is shrinking as the federal government solidifies its place as the largest single payer of prescription drugs. Thigpen is hopeful, however, that the rise of specialty pharmacy will provide consumers with more options. Albert Thigpen sits down with GLG to discuss PBMs, retail consumerism, and the major trends affecting American consumers.
Albert Thigpen most recently worked as Senior Vice President of Industry Relations and Supply Chain Management at Catamaran/Optum–the third largest PBM in the U.S. with over 61 million members. In his tenure, he managed pharmaceutical industry partnerships, which included $65 Billion in cost of goods relationships across the commercial PBM, government and public sector, and specialty business verticals. Prior to joining Catamaran i
•
Healthcare and entitlement reform expert Avik Roy sees two major problems in healthcare today: overly high drug prices and a bottleneck at the FDA. Progress, he argues, isn’t about health insurance but the innovation occurring in drug development. Echoing President-elect Trump, Roy would like to see more free market options to combat the rising cost of drugs, as well as a more streamlined drug-approval process.
“Nearly every dollar of growth in federal spending is driven by growth in healthcare spending.”
About Avik Roy
Avik Roy is the author of Transcending Obamacare and How Medicaid Fails the Poor. Roy is the President of the Foundation for Research on Equal Opportunity as well as the Managing Partner at Roy Healthcare Research, LLC, which provides proprietary healthcare investment and policy research to institutional investors and stakeholders. During the 2012 U.S. presidential campaign, Roy was a senior healthcare advisor to Mitt Romney, where he helpe
•